Boiron Faces New False Ad Suit Over Homeopathic Flu Drug
A plaintiff who opted out of a proposed $12 million false advertising class settlement with homeopathic medicine maker Boiron Inc. launched a separate suit Monday in California state court alleging the...To view the full article, register now.
Already a subscriber? Click here to view full article